vimarsana.com

Page 52 - நோய்த்தடுப்பு நடவடிக்கை கூட்டணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

USA TODAY panel says US has nailed the science behind COVID-19 vaccines, but logistics, trust remain a concern

USA TODAY panel says US has nailed the science behind COVID-19 vaccines, but logistics, trust remain a concern Karen Weintraub and Elizabeth Weise, USA TODAY © Javier Zarracina/USA Today promo vaccine panel dec Experts are thrilled about the reported safety and effectiveness of two COVID-19 vaccines rolling out across the country. But they remain concerned about what still could go wrong to shake the public s fragile faith in it. Nearly everything about the process has gone well so far, shepherded by the Trump administration s Operation Warp Speed. The first two vaccines, one from Pfizer-BioNTech and the other from Moderna, were ready well before anyone expected. Trials showed them to be among the most effective vaccines ever, particularly for a notoriously hard-to-prevent respiratory virus.

USA TODAY panel says US has nailed the science behind COVID-19 vaccine, but logistics, trust remain a concern

USA TODAY panel says US has nailed the science behind COVID-19 vaccines, but logistics, trust remain a concern Karen Weintraub and Elizabeth Weise, USA TODAY © Javier Zarracina/USA Today promo vaccine panel dec Experts are thrilled about the reported safety and effectiveness of two COVID-19 vaccines rolling out across the country. But they remain concerned about what still could go wrong to shake the public s fragile faith in it. Nearly everything about the process has gone well so far, shepherded by the Trump administration s Operation Warp Speed. The first two vaccines, one from Pfizer-BioNTech and the other from Moderna, were ready well before anyone expected. Trials showed them to be among the most effective vaccines ever, particularly for a notoriously hard-to-prevent respiratory virus.

COVID vaccine update: 100M more Pfizer doses; Trump rips stimulus

In the headlines:  ►Pfizer and BioNTech announced an agreement with the U.S. government to supply an additional 100 million doses of the companies’ vaccine. This agreement brings the total number of doses to be delivered to the U.S. by July 31 to 200 million. ►The AFC East champion Buffalo Bills are exploring a plan that would allow up to 6,700 fans to attend their remaining home games, including at least one in the playoffs. The plan, yet to be approved, calls for the use of rapid COVID-19 tests and contact tracing. ►Luke Letlow, a Louisiana Republican who was elected as a U.S. Representative in November, was transferred to the intensive care unit of a Shreveport hospital to continue treatment for COVID-19. Letlow, 40, is in stable condition.

Covid-19 Vaccine: Could Venues and Airlines Require Proof for Entry?

First, let’s talk about logistics. Back in April, Rolling Stone reported on the concept of immunity certificates or passports some type of documentation (electronic or paper) that would serve as proof that a person is immune from the novel coronavirus. And though much has changed since then both in terms of understanding the virus and now having two safe and effective vaccines Dr. L.J. Tan, an immunologist and the chief strategy officer of the Immunization Action Coalition (IAC), says that policies like these are still premature from a scientific standpoint.  Specifically, it is not yet known how long immunity from the Covid vaccine will last. “We haven’t got six months, nine months of duration of protection data yet,” Tan tells

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.